BASBone and Arthrosurgery Science3083-48562981-8222Bio-Byword Scientific Publishing Pty. Ltd.10.26689/bas.v4i2.14746ArticleTraditional Chinese Medicine Regulates Th17/Treg Balance to Improve Osteoporosis: A Review of Bone Immunomodulation Mechanisms and Therapeutic Prospectshttps://artdesignp.com/journal/BAS/4/2/10.26689/bas.v4i2.14746ZhuZhiyuan,JinXiaoyue,SunRongxin2026422026-05-14Osteoporosis (OP) is a metabolic bone disease characterized by reduced bone mass and destruction of bone microstructure, posing a serious threat to the health of the elderly population. Studies in osteoimmunology have revealed that an imbalance between Th17 cells and regulatory T cells (Treg) is a core immunopathological mechanism underlying OP: overactivation of Th17 cells promotes osteoclast differentiation and accelerates bone resorption, while impaired Treg function weakens bone protection, ultimately leading to disrupted bone metabolism. Traditional Chinese medicine (TCM), with its advantages in multi-target and holistic regulation, shows broad application prospects in restoring Th17/Treg balance and reshaping the bone immune microenvironment. This article systematically reviews the molecular mechanisms by which TCM compounds (e.g., Yishen Juanbi Pills, Jintiange Capsules) and active components (e.g., icariin, astragaloside IV) regulate T cell differentiation, with a focus on the involvement of signaling pathways such as NF-κB and Wnt/β-catenin, as well as the gut microbiota–short-chain fatty acids axis in mediating immune regulation. In addition, it summarizes preclinical and clinical research evidence supporting the use of TCM in treating OP. In response to current challenges, including insufficient target analysis and a lack of high-quality clinical evidence, this paper proposes that future efforts should integrate cutting-edge approaches such as multi-omics technologies, nano-delivery systems, and artificial intelligence to systematically elucidate the molecular network through which TCM regulates bone immunity. Such advances will facilitate the transition of TCM from experience-based to evidence-based medicine, providing safer and more effective immune-targeted therapeutic strategies for the prevention and management of OP.

Rizzoli R, Biver E, Brennan-Speranza TC, 2021, Nutritional Intake and Bone Health. Lancet Diabetes Endocrinol, 9(9): 606–621.

Wang YT, Zheng SY, Luo Y, et al., 2025, Osteoimmunology and Aging: Mechanisms, Implications, and Therapeutic Perspectives. Ageing Res Rev, 111: 102822.

Qi P, Xie R, Liu H, et al., 2024, Mechanisms of Gut Homeostasis Regulating Th17/Treg Cell Balance in PMOP. Front Immunol, 15: 1497311.

Chen F, Li J, Wang H, et al., 2021, Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment. Front Oncol, 11: 746917.

Deng Z, Zhang Q, Zhao Z, et al., 2021, Crosstalk between Immune Cells and Bone Cells or Chondrocytes. Int Immunopharmacol, 101(Pt A): 108179.

Li S, Liu G, Hu S, 2024, Osteoporosis: Interferon-Gamma-Mediated Bone Remodeling in Osteoimmunology. Front Immunol, 15: 1396122.

Luo J, Li L, Shi W, et al., 2025, Oxidative Stress and Inflammation: Roles in Osteoporosis. Front Immunol, 16: 1611932.

Fischer V, Haffner-Luntzer M, 2022, Interaction between Bone and Immune Cells: Implications for Postmenopausal Osteoporosis. Semin Cell Dev Biol, 123: 14-21.

Cheng X, Chen Y, Zhou X, et al., 2025, Immunoporosis: The Hidden Link between Aging Immune Cells and Bone Fragility. J Orthop Translat, 53: 325–335.

Zhou B, Li S, Song J, 2026, The Impact of Dyslipidemia on Skeletal Health - From an Immunoregulatory Perspective. Front Immunol, 17: 1774535.

Chen L, Zhao Y, Qiu J, et al., 2024, Analysis and Validation of Biomarkers of Immune Cell-Related Genes in Postmenopausal Osteoporosis: An Observational Study. Medicine (Baltimore), 103(19): e38042.

Bhadricha H, Patel V, Singh AK, et al., 2021, Increased Frequency of Th17 Cells and IL-17 Levels Are Associated with Low Bone Mineral Density in Postmenopausal Women. Sci Rep, 11(1): 16155.

Takahara C, Tabuchi N, Inoue H, et al., 2026, The Differences in Gut Microbiota Due to Dietary Habits Affect the Onset of Disease Pathology in a Dextran Sulfate Sodium-Induced Colitis Model. Biol Pharm Bull, 49(3): 438–451.

Qin X, Lian YE, Tang H, et al., 2025, Lactobacillus rhamnosus GG Mitigates Bone Loss Induced by Mechanical Unloading via Regulation of the Gut-Bone Axis. Front Nutr, 12: 1734220.

Wang Z, Luo J, Yu T, et al., 2026, BMSC-Derived Exosomes Facilitate Osteogenesis and Ameliorate Ageing-Related Bone Loss Through Restoring Th17/Treg Homeostasis via the miR-21/Skp2/FoxO1 Axis. Stem Cell Res Ther, 2026.

Lv J, Hao P, Zhou Y, et al., 2025, Role of the Intestinal Flora-Immunity Axis in the Pathogenesis of Rheumatoid Arthritis-Mechanisms Regulating Short-Chain Fatty Acids and Th17/Treg Homeostasis. Mol Biol Rep, 52(1): 617.

Sun P, Zhang C, Huang Y, et al., 2022, Jiangu Granule Ameliorated OVX Rats Bone Loss by Modulating Gut Microbiota-SCFAs-Treg/Th17 Axis. Biomed Pharmacother, 150: 112975.

Yan M, Yang M, Cai Y, et al., 2025, Progress in Multiaxial Coupling Mechanisms of Osteoporosis: Insights from Systems Medicine on Immune-Inflammatory Interactions, Hormonal Regulation, and Metabolic Imbalance. Front Endocrinol (Lausanne), 16: 1705040.

Bhardwaj A, Sapra L, Srivastava RK, 2026, Immunotherapeutic Potential of “Breg-Treg” vs “Th9-Th17” Cell Axis in Post-Menopausal Osteoporosis. Int Rev Immunol, 45(2): 77–98.

Shen Y, Wang Z, Tan J, et al., 2021, TRAF6/ERK/p38 Pathway Is Involved in Interleukin-17-Mediated Autophagy to Promote Osteoclast Precursor Cell Differentiation. Zhejiang Da Xue Xue Bao Yi Xue Ban, 50(2): 162–170.

Ni S, Fu W, Zhang L, et al., 2026, Circadian Rhythms Regulate Osteoclast Recycling Through Gut Microbiota-Dependent Th17 Cell Expansion. Curr Res Microb Sci, 10: 100561.

Takegahara N, Kim H, Choi Y, 2022, RANKL Biology. Bone, 159: 116353.

Wu Y, Ai H, Xi Y, et al., 2023, Osteoclast-Derived Apoptotic Bodies Inhibit Naive CD8⁺ T Cell Activation via Siglec15, Promoting Breast Cancer Secondary Metastasis. Cell Rep Med, 4(9): 101165.

Hua D, Yang J, Meng Q, et al., 2021, Soufeng Sanjie Formula Alleviates Collagen-Induced Arthritis in Mice by Inhibiting Th17 Cell Differentiation. Chin Med, 16(1): 39.

Li X, Chen S, et al., 2026, Systems-Level Molecular and Immunological Evidence Identifies Th17/Treg Modulation as A Key Mechanism of CRSJ’s Neuroprotection in Parkinson’s Disease. Front Aging Neurosci, 18: 1764634.

Zhang H, Liu J, Zhang P, et al., 2021, Herbal Formula Longteng Decoction Promotes the Regression of Synovial Inflammation in Collagen-Induced Arthritis Mice by Regulating Type 2 Innate Lymphocytes. Front Pharmacol, 12: 778845.

Lan H, Qiu W, Wu J, et al., 2024, Formononetin Reverses Treg/Th17 Imbalance in Immune-Mediated Bone Marrow Failure Mice by Regulating the PI3K/Akt Signaling Pathway. Chin Med, 19(1): 55.

Wang C, Shi S, Wang F, et al., 2026, A Biointerface-Engineered Gold Nanocluster Platform for Icariin Delivery: Dual-Pathway Modulation of Osteoblast and Osteoclast Dynamics in Osteoporosis Therapy. Biomater Adv, 183: 214773.

Zeng M, Wu Y, Ren Y, et al., 2025, A New Phenolic Acid Isolated from Salvia miltiorrhiza Ameliorates OVA-Induced Allergic Asthma by Regulation of Th17/Treg Cells and Inflammation Through the TLR4 Pathway. Chin J Nat Med, 23(12): 100007.

Zhang Z, Yang Z, Jia Z, et al., 2026, Optimized New Shengmai Powder Suppresses Ferroptosis in Ischemic Cardiomyocytes via cGMP-PKG Signalling. Chin Med, 21(1).

Ilic J, Bold A, Knop S, 2026, The Role of Epigenetic Modifications in Hematological Cancers. Front Oncol, 16: 1744018.

Li J, Ma Y, Li X, et al., 2022, Fermented Astragalus and Its Metabolites Regulate Inflammatory Status and Gut Microbiota to Repair Intestinal Barrier Damage in Dextran Sulfate Sodium-Induced Ulcerative Colitis. Front Nutr, 9: 1035912.

Sapra L, Saini C, Mishra PK, et al., 2025, Bacillus coagulans Ameliorates Inflammatory Bone Loss in Post-Menopausal Osteoporosis via Modulating the “Gut-Immune-Bone” Axis. Gut Microbes, 17(1): 2492378.

Li W, Ding Z, Chen Y, et al., 2022, Integrated Pharmacology Reveals the Molecular Mechanism of Gegen Qinlian Decoction Against Lipopolysaccharide-induced Acute Lung Injury. Front Pharmacol, 13: 854544.

Ho TL, Lee KT, He YH, et al., 2025, C-X-C Motif Chemokine Ligand 13 Suppresses Osteoclast Differentiation Via Interference with RANKL-RANK Interaction. Front Immunol, 16: 1729222.

Yifan G, Xiaohan X, Jie M, et al., 2026, Multi-Omics-Based Study on the Biological Characteristics of Kidney Renal Deficiency and Blood Stasis in Ankylosing Spondylitis. J Tradit Chin Med, 46(1): 183–194.

Zihao L, Jie G, Jinyun S, et al., 2026, Network Pharmacological and Experimental Validation of the Mechanism of Chaihu Guizhi Ganjiang Decoction Regulating T Helper Cell 17/Regulatory T Cell Balance to Improve Autoimmune Hepatitis. J Tradit Chin Med, 46(1): 110–118.

Zhang P, Lin L, Wang N, et al., 2025, Yougui Pills Prevent Ovariectomy-Induced Bone Loss by Suppressing Th17 Response and IL-17/NF-κB Pathway. Ann Med, 57(1): 2529576.

Zhang H, Li Y, Yuan L, et al., 2021, Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis. Front Endocrinol (Lausanne), 12: 642676.

Gong S, Xu R, Wang Y, et al., 2025, Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways. Pharmaceuticals (Basel), 18(2): 141.

Gong N, Wang L, An L, et al., 2023, Exploring the Active Ingredients and Potential Mechanisms of Action of Sinomenium acutum in the Treatment of Rheumatoid Arthritis Based on Systems Biology and Network Pharmacology. Front Mol Biosci, 10: 1065171.

Zhang Y, He X, Wang K, et al., 2024, Irisin Alleviates Obesity-Induced Bone Loss by Inhibiting Interleukin 6 Expression via TLR4/MyD88/NF-κB Axis in Adipocytes. J Adv Res, 69: 343–359.

Xia Y, Fan D, Li X, et al., 2021, Yi Shen Juan Bi Pill Regulates the Bone Immune Microenvironment via the JAK2/STAT3 Signaling Pathway In Vitro. Front Pharmacol, 12: 746786.

Zhuang C, Wang Z, Chen W, et al., 2021, Jintiange Capsules Ameliorate Osteoarthritis by Modulating Subchondral Bone Remodeling and Protecting Cartilage Against Degradation. Front Pharmacol, 12: 762543.

Li J, Cao H, Zhou X, et al., 2023, Advances in the Study of Traditional Chinese Medicine Affecting Bone Metabolism Through Modulation of Oxidative Stress. Front Pharmacol, 14: 1235854.

Peng Z, Xu R, You Q, 2022, Role of Traditional Chinese Medicine in Bone Regeneration and Osteoporosis. Front Bioeng Biotechnol, 10: 911326.

Shen D, Feng Y, Zhang X, et al., 2022, Antiosteoporosis Studies of 20 Medicine Food Homology Plants Containing Quercetin, Rutin, and Kaempferol: TCM Characteristics, In Vivo and In Vitro Activities, Potential Mechanisms, and Food Functions. Evid Based Complement Alternat Med, 2022: 5902293.

Liew KY, Chee HY, Abas F, et al., 2025, Curcumin-Like Diarylpentanoid Analogues Exhibit Antiviral and Anti-Inflammatory Activities in Influenza A Virus-Infected A549 Lung Epithelial Cells by Inhibiting Multiple Retinoic Acid-Inducible Gene I (RIG-I)-Mediated Pathways. Virol J, 22(1): 343.

Ahmed RH, Rashad Ahmed R, Galaly SR, et al., 2024, Mesenchymal Stem Cells and Curcumin Effectively Mitigate Freund’s Adjuvant-Induced Arthritis via their Anti-Inflammatory and Gene Expression of COX-1, IL-6 and IL-4. Endocr Metab Immune Disord Drug Targets, 24(4): 468–488.

Zhu K, Yang C, Dai H, et al., 2019, Crocin Inhibits Titanium Particle-Induced Inflammation and Promotes Osteogenesis by Regulating Macrophage Polarization. Int Immunopharmacol, 76: 105865.

El Midaoui A, Ghzaiel I, Vervandier-Fasseur D, et al., 2022, Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases. Nutrients, 14(3): 597.

de Molon RS, 2025, Therapeutic Potential of Tanshinones in Osteolytic Diseases: From Molecular and Cellular Pathways to Preclinical Models. Dent J (Basel), 13(7): 309.